Greenwich Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Greenwich Wealth Management LLC

$1.47 Billion
Q3 2024

A detailed history of Greenwich Wealth Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Greenwich Wealth Management LLC holds 16,067 shares of REGN stock, worth $11.3 Million. This represents 1.15% of its overall portfolio holdings.

Number of Shares

16,067

Previous 16,079 0.07%

Holding current value

$11.3 Million

Previous $16.9 Million 0.05%

% of portfolio

1.15%

Previous 1.23%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$1024.09 - $1201.76 $12,289 - $14,421	-12 Reduced 0.07%	16,067 $16.9 Million
Q2 2024 Aug 09, 2024	SELL	$883.2 - $1071.19 $883 - $1,071	-1 Reduced 0.01%	16,079 $16.9 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $4,513 - $4,966	5 Added 0.03%	16,080 $15.5 Million
Q4 2023 Feb 01, 2024	SELL	$775.18 - $881.7 $15,503 - $17,634	-20 Reduced 0.12%	16,075 $14.1 Million
Q3 2023 Nov 07, 2023	BUY	$692.45 - $844.37 $16,618 - $20,264	24 Added 0.15%	16,095 $13.2 Million
Q2 2023 Jul 31, 2023	SELL	$700.03 - $830.35 $23,801 - $28,231	-34 Reduced 0.21%	16,071 $11.5 Million
Q1 2023 Apr 24, 2023	SELL	$680.49 - $826.97 $4,763 - $5,788	-7 Reduced 0.04%	16,105 $13.2 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $27,529 - $29,889	-39 Reduced 0.24%	16,112 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $6,887 - $8,691	12 Added 0.07%	16,151 $11.1 Million
Q2 2022 Aug 08, 2022	SELL	$548.35 - $738.84 $13,708 - $18,471	-25 Reduced 0.15%	16,139 $9.54 Million
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $7,065 - $8,722	-13 Reduced 0.08%	16,164 $10.2 Million
Q3 2021 Oct 19, 2021	SELL	$574.03 - $680.96 $35,015 - $41,538	-61 Reduced 0.38%	16,177 $9.79 Million
Q2 2021 Jul 27, 2021	BUY	$472.8 - $558.54 $27,895 - $32,953	59 Added 0.36%	16,238 $9.07 Million
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $22,336 - $27,410	50 Added 0.31%	16,179 $7.66 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $29,654 - $37,694	62 Added 0.39%	16,129 $7.79 Million
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $1,089 - $1,316	2 Added 0.01%	16,067 $8.99 Million
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $49,332 - $64,391	-100 Reduced 0.62%	16,065 $10 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $5.43 Million - $7.99 Million	16,165 New	16,165 $7.89 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwich Wealth Management LLC with notifications on news.

Account

Greenwich Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History